Trials / Completed
CompletedNCT01091714
Is Omega-3 Fatty Acid Red Blood Cell (RBC) Saturation Product Dependent?
Is Omega-3 Fatty Acid RBC Saturation Product Dependent?
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Bucci Laser Vision Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate that RBC saturation of the Omega-3 fatty acids reaching cardioprotective levels as proven with the HS-Omega-3 Index test will be achieved most efficiently depending on a specific product utilized within this study.
Detailed description
To demonstrate that RBC saturation of the Omega-3 fatty acids reaching cardioprotective levels as proven with the HS-Omega-3 Index test will be achieved most efficiently depending on a specific product utilized within this study. The HS-Omega-3 Index is a new test that measures blood levels of the cardioprotective omega-3 fatty acids, EPA and DHA. RBS saturation is being measured to identify how much Omega 3 is in the blood.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Omega-3 | Approximately 2400 mg of Omega-3s taken once daily by capsule, taken for the duration of the study. |
| DIETARY_SUPPLEMENT | Omega-3 | Approximately 2240 mg of Omega-3s taken once daily by capsule, taken for the duration of the study. |
| DIETARY_SUPPLEMENT | Omega-3 | Approximately 2332 mg of Omega-3s taken once daily by capsule, taken for the duration of the study. |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2010-03-24
- Last updated
- 2011-10-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01091714. Inclusion in this directory is not an endorsement.